Skip to main content

Published locations for In critically ill patients, dalteparin is more cost-effective for VTE prevention

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. In critically ill patients, dalteparin is more cost-effective for VTE prevention

User login

  • Reset your password
  • /content/critically-ill-patients-dalteparin-more-cost-effective-vte-prevention
  • /ehospitalistnews/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost-effective
  • /internalmedicinenews/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost
  • /acssurgerynews/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost-effective
  • /vascularspecialistonline/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost
  • /anticoagulationhub/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost
  • /internalmedicine/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost-effective
  • /surgery/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost-effective-vte
  • /chestphysician/article/88375/critical-care/critically-ill-patients-dalteparin-more-cost-effective